InsidersTradesSigma
梅花生物 Stock: price and management transactions · China · SSE / SZSE (CSRC)
Follow the 梅花生物 stock price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on CN CN, under the authority of SSE / SZSE (CSRC). Operating in the Chemicals sector, 梅花生物 has recorded 9 insider filings. Market capitalisation: €24.8bn. The latest transaction was disclosed on 30 April 2026 (Purchase). Among the most active insiders: 常利斌. All data is accessible without an account.
9
Insider Decl.
0
Thresholds
·
8 ops.
Buy Volume
·
1 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 2,162 of 25,750 companies
75.3
score / 100
Value87
Quality63
FCF yld8.4%
Earn yld14%
EV/EBITDA5.2x
ROE15%
Gross mgn19%
Net mgn14%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 April 2026
Declarations9 total
9 of 9 declarations